Eulav Asset Management Jazz Pharmaceuticals PLC Transaction History

Eulav Asset Management

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$125.18 - $143.24 $5.63 Million - $6.45 Million	-45,000 Closed	0 $0
Q2 2019 Aug 05, 2019	SELL	$125.55 - $144.48 $1.38 Million - $1.59 Million	-11,000 Reduced 19.64%	45,000 $6.42 Million
Q1 2019 May 13, 2019	BUY	$121.81 - $142.95 $2.44 Million - $2.86 Million	20,000 Added 55.56%	56,000 $8.01 Million
Q4 2018 Feb 14, 2019	SELL	$115.94 - $166.74 $1.39 Million - $2 Million	-12,000 Reduced 25.0%	36,000 $4.46 Million
Q3 2018 Oct 26, 2018	SELL	$161.01 - $180.57 $161,010 - $180,570	-1,000 Reduced 2.04%	48,000 $8.07 Million

Q2 2018 Aug 14, 2018	SELL	$146.33 - $183.18 $1.17 Million - $1.47 Million	-8,000 Reduced 14.04%	49,000 $8.44 Million
Q1 2018 May 09, 2018	SELL	$135.59 - $157.16 $1.63 Million - $1.89 Million	-12,000 Reduced 17.39%	57,000 $8.61 Million
Q4 2017 Feb 14, 2018	SELL	$131.06 - $150.39 $3.54 Million - $4.06 Million	-27,000 Reduced 28.13%	69,000 $9.29 Million
Q3 2017 Nov 14, 2017	SELL	$142.62 - $155.6 $570,480 - $622,400	-4,000 Reduced 4.0%	96,000 $14 Million
Q2 2017 Aug 14, 2017	BUY	N/A	100,000	100,000 $15.6 Million

513

57M

65.9K

183K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.59B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Eulav Asset Management, based on Form 13F filings with the SEC.

Stay updated on Eulav Asset Management with notifications on news.